DEF 14A: Definitive information statements
Apr 26 16:51 ET
DEFA14A: Others
Apr 26 16:50 ET
Bionano Genomics | 8-K: Bionano Genomics Filed a Prospectus Supplement
Apr 8 16:58 ET
Bionano Genomics | 424B5: Prospectus
Apr 8 08:47 ET
Bionano Genomics | 8-K: Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Apr 5 09:33 ET
Bionano Genomics | ARS: Annual Report to Security Holders
Mar 6 12:33 ET
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Chaubey Alka
Mar 5 17:54 ET
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Dixon Jonathan V.
Mar 5 17:50 ET
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Holmlin R. Erik
Mar 5 17:50 ET
Bionano Genomics | 4: Statement of changes in beneficial ownership of securities-Officer OLDAKOWSKI MARK
Mar 5 17:49 ET
Bionano Genomics | 10-K: Annual report
Mar 5 17:30 ET
Bionano Genomics | 8-K: Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024
Mar 5 16:29 ET
Bionano Genomics | 8-K: Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway
Feb 28 08:17 ET
Bionano Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.88%)
Feb 13 18:10 ET
Bionano Genomics | 8-K: Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results
Jan 8 00:00 ET
Bionano Genomics | 8-K: Current report
Nov 24, 2023 13:05 ET
Bionano Genomics | 424B3: Prospectus
Nov 8, 2023 16:52 ET
Bionano Genomics: Q3 2023 Earnings Report
Nov 8, 2023 16:20 ET
Bionano Genomics | 8-K: Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress
Nov 8, 2023 16:02 ET
Bionano Genomics | EFFECT: Others
Nov 7, 2023 00:15 ET
No Data
No Data